Moolec Science SA (MLEC)
NASDAQ: MLEC · Real-Time Price · USD
2.690
+0.039 (1.48%)
At close: Aug 13, 2025, 4:00 PM
2.700
+0.010 (0.37%)
After-hours: Aug 13, 2025, 5:04 PM EDT
Moolec Science Statistics
Total Valuation
Moolec Science has a market cap or net worth of $10.79 million.
Market Cap | 10.79M |
Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Wednesday, October 1, 2025, before market open.
Earnings Date | Oct 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Moolec Science has 4.01 million shares outstanding. The number of shares has increased by 1.44% in one year.
Current Share Class | 4.01M |
Shares Outstanding | 4.01M |
Shares Change (YoY) | +1.44% |
Shares Change (QoQ) | +0.72% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.00% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 2.45 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 52 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.81% in the last 52 weeks. The beta is -0.32, so Moolec Science's price volatility has been lower than the market average.
Beta (5Y) | -0.32 |
52-Week Price Change | -69.81% |
50-Day Moving Average | 5.21 |
200-Day Moving Average | 7.20 |
Relative Strength Index (RSI) | 20.71 |
Average Volume (20 Days) | 67,659 |
Short Selling Information
The latest short interest is 65,322, so 1.63% of the outstanding shares have been sold short.
Short Interest | 65,322 |
Short Previous Month | 4,655 |
Short % of Shares Out | 1.63% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.46 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | -8.08M |
Net Income | n/a |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | n/a |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | n/a |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | -6.10M |
FCF Per Share | -$1.52 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Moolec Science does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.44% |
Shareholder Yield | -1.44% |
Earnings Yield | n/a |
FCF Yield | -60.80% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | 105.08% |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |